Table 2.
Distribution of the Edmonton Symptom Assessment System Scores of the Intervention and Control Groups
| Components | Measurement | Control Group | Intervention Group | ϢZ | p |
|---|---|---|---|---|---|
| X ± SD (Min - Max) | X ± SD (Min - Max) | ||||
| Pain | 1st measurement (1) | 1.87 ± 2.60 (0 - 9) | 0.73 ± 1.55 (0 - 5) | -1.918 | 0.055 |
| 2nd measurement (2) | 2.57 ± 2.67 (0 - 8) | 1.57 ± 1.98 (0 - 7) | -1.625 | 0.104 | |
| 3rd measurement (3) | 2.40 ± 2.44 (0 - 8) | 1.60 ± 1.89 (0 - 5) | -1.268 | 0.205 | |
| 4th measurement (4) | 1.93 ± 2.24 (0 - 6) | 0.53 ± 1.11 (0 - 3) | -2.734 | 0.006* | |
| Test Statistics | ΨX2=11.660, p=0.112 | ΨX2=57.942, p=0.000* | |||
| 1<2, 2>3 | |||||
| Tiredness | 1st measurement (1) | 4.20 ± 2.67 (0 - 10) | 4.23 ± 1.96 (0 - 8) | -0.06 | 0.952 |
| 2nd measurement (2) | 5.33 ± 2.52 (0 - 10) | 4.63 ± 2.17 (0 - 8) | -0.896 | 0.37 | |
| 3rd measurement (3) | 4.87 ± 3.09 (0 - 10) | 4.37 ± 2.03 (0 - 8) | -1.031 | 0.302 | |
| 4th measurement (4) | 4.17 ± 3.06 (0 - 10) | 3.70 ± 2.02 (0 - 8) | -0.747 | 0.455 | |
| Test Statistics | ΨX2=34.593, p=0.000* | ΨX2=66.438, p=0.000* | |||
| 1<2, 2>3 | 1>3, 2>3 | ||||
| Nausea | 1st measurement (1) | 2.23 ± 2.64 (0 - 8) | 0.33 ± 1.37 (0 - 7) | -3.778 | 0.000* |
| 2nd measurement (2) | 4.20 ± 2.82 (0 - 10) | 3.27 ± 2.15 (0 - 10) | -1.12 | 0.263 | |
| 3rd measurement (3) | 2.80 ± 2.55 (0 - 7) | 1.57 ± 1.98 (0 - 6) | -1.941 | 0.052 | |
| 4th measurement (4) | 1.73 ± 2.55 (0 - 8) | 0.20 ± 0.66 (0 - 3) | -2.849 | 0.004* | |
| Test Statistics | ΨX2=43.357, p=0.000* | ΨX2=93.876, p=0.000* | |||
| 1<2, 2>3 | 1<2, 2>3 | ||||
| Depression | 1st measurement (1) | 4.87 ± 3.37 (0 - 10) | 4.60 ± 2.39 (0 - 10) | -0.298 | 0.766 |
| 2nd measurement (2) | 4.77 ± 3.10 (0 - 10) | 4.63 ± 2.27 (0 - 8) | -0.225 | 0.822 | |
| 3rd measurement (3) | 4.27 ± 2.49 (0 - 9) | 4.37 ± 2.17 (0 - 8) | -0.067 | 0.946 | |
| 4th measurement (4) | 3.87 ± 2.75 (0 - 10) | 3.53 ± 1.80 (0 - 6) | -0.531 | 0.595 | |
| Test Statistics | ΨX2=16.231, p=0.023* | ΨX2=73.299, p=0.000* | |||
| 1>3, 2>3 | |||||
| Anxiety | 1st measurement (1) | 5.07 ± 3.29 (0 - 10) | 5.00 ± 2.29 (0 - 10) | -0.082 | 0.935 |
| 2nd measurement (2) | 4.83 ± 3.04 (0 - 10) | 5.00 ± 2.27 (0 - 9) | -0.246 | 0.806 | |
| 3rd measurement (3) | 4.43 ± 2.64 (0 - 10) | 4.83 ± 2.21 (0 - 8) | -0.695 | 0.487 | |
| 4th measurement (4) | 4.27 ± 2.92 (0 - 10) | 3.87 ± 1.93 (0 - 8) | -0.689 | 0.491 | |
| Test Statistics | ΨX2=12.036, p=0.099 | ΨX2=84.776, p=0.000* | |||
| 1>3, 2>3 | |||||
| Drowsiness | 1st measurement (1) | 4.23 ± 3.74 (0 - 10) | 3.47 ± 2.29 (0 - 8) | -0.507 | 0.612 |
| 2nd measurement (2) | 4.57 ± 3.65 (0 - 10) | 3.97 ± 2.27 (0 - 8) | -0.581 | 0.561 | |
| 3rd measurement (3) | 4.17 ± 3.15 (0 - 9) | 3.63 ± 2.34 (0 - 8) | -0.746 | 0.456 | |
| 4th measurement (4) | 4.03 ± 2.99 (0 - 10) | 3.17 ± 2.07 (0 - 8) | -1.413 | 0.158 | |
| Test Statistics | ΨX2=17.516, p=0.014* | ΨX2=46.997, p=0.000* | |||
| 2>3 | 2>3 | ||||
| Appetite | 1st measurement (1) | 3.80 ± 3.27 (0 - 10) | 2.97 ± 2.36 (0 - 10) | -0.8 | 0.424 |
| 2nd measurement (2) | 5.07 ± 3.36 (0 - 10) | 4.13 ± 2.47 (0 - 10) | -1.187 | 0.235 | |
| 3rd measurement (3) | 4.43 ± 3.38 (0 - 10) | 3.83 ± 2.35 (0 - 10) | -0.723 | 0.469 | |
| 4th measurement (4) | 4.03 ± 3.35 (0 - 10) | 2.73 ± 1.93 (0 - 7) | -1.184 | 0.236 | |
| Test Statistics | ΨX2=30.197, p=0.000* | ΨX2=76.352, p=0.000* | |||
| 1<2, 2>4 | 1<2, 2>3 | ||||
| Well-being | 1st measurement (1) | 4.90 ± 2.71 (0 - 10) | 4.67 ± 2.31 (0 - 10) | -0.525 | 0.6 |
| 2nd measurement (2) | 5.47 ± 2.83 (0 - 10) | 4.97 ± 2.33 (0 - 9) | -0.693 | 0.488 | |
| 3rd measurement (3) | 5.20 ± 2.50 (0 - 10) | 4.90 ± 2.07 (0 - 8) | -0.598 | 0.55 | |
| 4th measurement (4) | 4.47 ± 2.56 (0 - 10) | 4.00 ± 1.93 (0 - 8) | -0.772 | 0.44 | |
| Test Statistics | ΨX2=50.687, p=0.000* | ΨX2=75.554, p=0.000* | |||
| 2>4, 2>3 | 1<2, 1>4, 2>4, 2>3 | ||||
| Shortness of breath | 1st measurement (1) | 0.73 ± 2.15 (0 - 10) | 0.20 ± 0.81 (0 - 4) | -1.207 | 0.228 |
| 2nd measurement (2) | 0.80 ± 2.16 (0 - 10) | 0.37 ± 1.00 (0 - 4) | -0.695 | 0.487 | |
| 3rd measurement (3) | 0.77 ± 2.14 (0 - 10) | 0.40 ± 1.10 (0 - 4) | -0.428 | 0.668 | |
| 4th measurement (4) | 0.67 ± 1.79 (0 - 7) | 0.40 ± 1.10 (0 - 4) | -0.15 | 0.881 | |
| Test Statistics | ΨX2=10.996, p=0.139 | ΨX2=14.261, p=0.047* | |||
| Changes in skin/nails | 1st measurement (1) | 2.47 ± 2.22 (0 - 8) | 1.57 ± 1.87 (0 - 5) | -1.56 | 0.119 |
| 2nd measurement (2) | 2.77 ± 2.46 (0 - 9) | 2.10 ± 2.09 (0 - 6) | -1.01 | 0.313 | |
| 3rd measurement (3) | 2.67 ± 2.35 (0 - 9) | 1.93 ± 1.76 (0 - 5) | -1.104 | 0.269 | |
| 4th measurement (4) | 2.73 ± 2.56 (0 - 10) | 1.60 ± 1.57 (0 - 4) | -1.595 | 0.111 | |
| Test Statistics | ΨX2=8.113, p=0.323 | ΨX2=37.278, p=0.000* | |||
| 1<2, 2>4 | |||||
| Sore in the mouth | 1st measurement (1) | 1.37 ± 1.59 (0 - 6) | 0.37 ± 0.76 (0 - 2) | -2.798 | 0.005* |
| 2nd measurement (2) | 1.77 ± 1.70 (0 - 5) | 2.03 ± 1.16 (0 - 5) | -0.917 | 0.359 | |
| 3rd measurement (3) | 2.43 ± 1.94 (0 - 7) | 2.30 ± 0.95 (0 - 5) | -0.15 | 0.881 | |
| 4th measurement (4) | 2.33 ± 2.23 (0 - 8) | 0.97 ± 1.67 (0 - 8) | -2.969 | 0.003* | |
| Test Statistics | ΨX2=25.808, p=0.001* | ΨX2=109.157, p=0.000* | |||
| 1<2, 3<4 a | 1<2, 3>4, 2>4 | ||||
| Numbness in the Hands | 1st measurement (1) | 0.70 ± 1.73 (0 - 8) | 0.47 ± 1.28 (0 - 5) | -0.627 | 0.531 |
| 2nd measurement (2) | 0.80 ± 1.69 (0 - 8) | 0.63 ± 1.25 (0 - 4) | -0.254 | 0.8 | |
| 3rd measurement (3) | 0.80 ± 2.12 (0 - 8) | 0.47 ± 1.28 (0 - 5) | -0.393 | 0.695 | |
| 4th measurement (4) | 0.73 ± 1.76 (0 - 8) | 0.43 ± 1.22 (0 - 5) | -0.695 | 0.487 | |
| Test Statistics | ΨX2=4.003, p=0.779 | ΨX2=18.595, p=0.010* |
Ψ, Friedman Test; Ϣ, Mann Whitney U Test*p<0.05; a, Bonferroni Post-hoc Test